Stocks and Investing Stocks and Investing
Tue, April 23, 2024

Mathew Blackman Maintained (TNDM) at Strong Buy with Increased Target to $40 on, Apr 23rd, 2024


Published on 2024-10-28 10:33:25 - WOPRAI, Mathew Blackman
  Print publication without navigation


Mathew Blackman of Stifel, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Strong Buy with Increased Target from $37 to $40 on, Apr 23rd, 2024.

Mathew has made no other calls on TNDM in the last 4 months.



There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, all agree with Mathew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $38 on, Wednesday, April 3rd, 2024
  • Rick Wise of "Stifel" Maintained at Hold with Increased Target to $24 on, Monday, February 5th, 2024

Contributing Sources